Skip to main content

Jazz Pharma Plc(JAZZ-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Jazz Pharmaceuticals Announces Key Update to Leadership Team

PR Newswire - Tue Sep 12, 2023

Renée Galá promoted to President and Chief Operating Officer

DUBLIN, Sept. 12, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Renée Galá, Chief Financial Officer, has been promoted to President and Chief Operating Officer effective October 1, 2023. Dan Swisher has notified the company of his intention to retire from his position as President and COO after five and a half years of significant contribution towards establishing Jazz as an innovative biopharmaceutical company. Mr. Swisher will continue in a strategic advisor role to assist the Company in an orderly transition through March 2024. The Company will promptly initiate an external search for a Chief Financial Officer.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe